Development and Validation of UV Spectrophotometric Method for Determination of Tepotinib in Bulk and Pharmaceutical Dosage Forms-Reference-Cited by-同舟云学术

Development and Validation of UV Spectrophotometric Method for Determination of Tepotinib in Bulk and Pharmaceutical Dosage Forms

Published:2024-03-12 Issue: Volume: Page:
ISSN:
Container-title:
language:
Short-container-title:

Author:

Kumar Meruva Sathish¹^ORCID,Mrs.S.Marakatham ²,Polampalli Phani Deepika¹,Prasad S.Siva¹

Affiliation:

1. MNR College of Pharmacy,Fasalwadi Sangareddy, Telangana - 502294.

2. Malla Reddy Institute of Pharmaceutical Sciences,Maisammaguda,Telangana-500100

Abstract

Abstract The aim of this study was to develop a new, rapid and highly sensitive UV spectrophometer method for the Tepotinib bulk drug. The mobile phase consisted of Water & Acetonitrile in the ration of 50:50v/v and the wavelength to maximum absorbance at 256.0 nm. Analytical calibration curves were linear within a concentration range from 2.5 to 15µg/ml and coefficient of correlation 0.999. %RSD was found to be less than 2. The result of analysis has been validated statistically. This method will be validated in accordance with ICH requirements included the linearity, precision, accuracy sensitivity, and specificity. Hence the proposed method can be used for the reliable quantification of Tepotinib in tablet formulation.

Publisher

Research Square Platform LLC

Reference14 articles.

1. MarkhamA.Tepotinib:First approval Drugs.2020;80(8):829 – 33.10.1007/s40265 020-01317-9,PMID32361823

2. Tepotinib in non-small-cell lung cancer with MET Exon14skipping mutations;Paik PK;N Engl J Med,2020

3. Method development and validation of tepotinib by using reverse phase liquid chromatography in bulk and pharmaceutical dosage form;Raviteja G;Biosc Biotech Res Comm,2021

4. VijayaSriK. Method development and validation for the estimation of tepotinib in pharmaceutical dosage forms by RP-HPLC.IntJPharm PharmResHum (2022) ;26(1):468 – 77

5. Ramole R, Baile M (2021) A review: analytical method development and validation. SystRevPharm.;12(8):450-4